Found: 6
Select item for more details and to access through your institution.
Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell lines.
- Published in:
- International Journal of Cancer, 1999, v. 80, n. 3, p. 413, doi. 10.1002/(SICI)1097-0215(19990129)80:3<413::AID-IJC13>3.0.CO;2-I
- By:
- Publication type:
- Article
Prognostic relevance of mitotic activity in patients with node-negative breast cancer.
- Published in:
- 2004
- By:
- Publication type:
- Correction Notice
Prognostic Relevance of Mitotic Activity in Patients with Node-Negative Breast Cancer.
- Published in:
- Modern Pathology, 2003, v. 16, n. 11, p. 1067, doi. 10.1097/01.MP.0000093625.20366.9D
- By:
- Publication type:
- Article
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920985632
- By:
- Publication type:
- Article
Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/1758835920985632
- By:
- Publication type:
- Article
Phase III randomized multicenter study on the effects of adjuvant CMF in patients with node-negative, rapidly proliferating breast cancer: twelve-year results and retrospective subgroup analysis.
- Published in:
- Breast Cancer Research & Treatment, 2008, v. 108, n. 2, p. 259, doi. 10.1007/s10549-007-9593-9
- By:
- Publication type:
- Article